Skip to main content

Adela Rambi Guanco Cardones

Adjunct Associate Professor in the Department of Dermatology
Dermatology

Selected Grants


A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Cost Reimbursable

Clinical TrialCollaborator · Awarded by Food and Drug Administration · 2017 - 2022

Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker

ResearchPrincipal Investigator · Awarded by MicroElastic Ultrasound Systems, Inc. · 2019 - 2022

Keratinocyte targeted strategies for treatment of cutaneous GVHD

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2021

A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Cost Reimbursable

Clinical TrialCollaborator · Awarded by Food and Drug Administration · 2017 - 2022

Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker

ResearchPrincipal Investigator · Awarded by MicroElastic Ultrasound Systems, Inc. · 2019 - 2022

Keratinocyte targeted strategies for treatment of cutaneous GVHD

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2021

Effect of Dupilumab (anti-IL4R¿) on the Host-Microbe Interface in Atopic Dermatitis ATOPIC DERMATITIS RESEARCH NETWORK (ADRN)

Clinical TrialPrincipal Investigator · Awarded by National Jewish Health · 2018 - 2021

Pilot Study Evaluating the Efficacy of a Topical PDE-4 Inhibitor for Morphea

Clinical TrialPrincipal Investigator · Awarded by Pfizer, Inc. · 2017 - 2020

Quantitative Assessment of Disease Severity in Chronic Cutaneous Graft vs Host Disease

FellowshipPrincipal Investigator · Awarded by Dermatology Foundation · 2012 - 2015

External Relationships


  • MicroElastic Ultrasound Systems Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.